Strategies for targeted drug delivery in treatment of colon cancer: current trends and future perspectives

A Banerjee, S Pathak, VD Subramanium… - Drug discovery today, 2017 - Elsevier
Highlights•Review summarizes the current status of colon cancer and its management
strategies.•Features nanoformulated targeted delivery of anticancer drugs for colon cancer …

Molecular dynamics: new frontier in personalized medicine

P Sneha, CGP Doss - Advances in protein chemistry and structural biology, 2016 - Elsevier
The field of drug discovery has witnessed infinite development over the last decade with the
demand for discovery of novel efficient lead compounds. Although the development of novel …

[HTML][HTML] Similar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistance

M Morkel, P Riemer, H Bläker, C Sers - Oncotarget, 2015 - ncbi.nlm.nih.gov
Colorectal cancer (CRC) is characterized by recurrent mutations deregulating key cell
signaling cascades and providing the cancer cells with novel functional traits. Among the …

[HTML][HTML] Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 years

M Panczyk - World Journal of Gastroenterology: WJG, 2014 - ncbi.nlm.nih.gov
During the past two decades the first sequencing of the human genome was performed
showing its high degree of inter-individual differentiation, as a result of large international …

[HTML][HTML] Mutant KRAS as a critical determinant of the therapeutic response of colorectal cancer

K Knickelbein, L Zhang - Genes & diseases, 2015 - Elsevier
Mutations in the KRAS oncogene represent one of the most prevalent genetic alterations in
colorectal cancer (CRC), the third leading cause of cancer-related death in the US. In …

Polymeric nanoparticles for colon cancer therapy: overview and perspectives

X You, Y Kang, G Hollett, X Chen, W Zhao… - Journal of materials …, 2016 - pubs.rsc.org
Polymeric nanoparticles for colon cancer therapy: overview and perspectives - Journal of
Materials Chemistry B (RSC Publishing) DOI:10.1039/C6TB01925K Royal Society of …

TGFα and amphiregulin paracrine network promotes resistance to EGFR blockade in colorectal cancer cells

S Hobor, BO Van Emburgh, E Crowley, S Misale… - Clinical Cancer …, 2014 - AACR
Purpose: Targeted inhibition of EGFR with the mAbs cetuximab or panitumumab is a
valuable treatment for RAS wild-type colorectal cancers. The efficacy of EGFR blockade is …

[HTML][HTML] Perspective: Does personalized medicine hold the future for medicine?

AA Agyeman, R Ofori-Asenso - Journal of Pharmacy and Bioallied …, 2015 - journals.lww.com
W ith the upsurge of personalizing virtually anything such as mugs, stationery, T‑shirts,
phone cases, gift items and most recently the ongoing personalized Coca‑Cola UK summer …

Personalized transcranial magnetic stimulation in psychiatry

L Cocchi, A Zalesky - Biological Psychiatry: Cognitive Neuroscience and …, 2018 - Elsevier
Transcranial magnetic stimulation (TMS) is a noninvasive brain stimulation technique that
allows for modulating the activity of local neural populations and related neural networks …

Clonal interactions in cancer: Integrating quantitative models with experimental and clinical data

ND Lee, K Kaveh, I Bozic - Seminars in Cancer Biology, 2023 - Elsevier
Tumors consist of different genotypically distinct subpopulations—or subclones—of cells.
These subclones can influence neighboring clones in a process called “clonal interaction.” …